scispace - formally typeset
Open AccessJournal ArticleDOI

Androgen receptor coregulator long noncoding RNA CTBP1-AS is associated with polycystic ovary syndrome in Kashmiri women.

Reads0
Chats0
TLDR
The mean expression level of CTBP1-AS was found to be significantly higher in the PCOS women than in the healthy controls, and high expression of CTBA-AS is a risk factor for PCOS in Kashmiri women.
Abstract
Polycystic ovary syndrome (PCOS) is one of the most common reproductive, endocrine, and metabolic disorder in premenopausal women. Even though the pathophysiology of PCOS is complex and obscure, the disorder is prominently considered as the syndrome of hyperandrogenism. C-Terminal binding protein 1 antisense (CTBP1-AS) acts as a novel androgen receptor regulating long noncoding RNA (lncRNA). Therefore, the present study was aimed to establish the possible association of androgen receptor regulating long noncoding RNA CTBP1-AS with PCOS. A total of 178 subjects including 105 PCOS cases and 73 age-matched healthy controls were recruited for the study. The anthropometric, hormonal, and biochemical parameters of all subjects were analyzed. Total RNA was isolated from peripheral venous blood and expression analysis was done by quantitative real-time PCR. The correlation analysis was performed to evaluate the association between and various clinical parameters and lncRNA CTBP1-AS expression. The mean expression level of CTBP1-AS was found to be significantly higher in the PCOS women than in the healthy controls (-lnCTBP1-AS, 4.23 ± 1.68 versus 1.24 ± 0.29, P < 0.001). Furthermore, subjects with higher expression level of CTBP1-AS had significantly higher risk of PCOS compared to subjects with low levels of CTBP1-AS expression (actual OR = 11.36, 95% CI = 5.59–23.08, P < 0.001). The area under receiver operator characteristic (ROC) curve was 0.987 (SE 0.006, 95% CI 0.976–0.99). However, lncRNA CTBP1-AS was found to have no association with different clinical characteristics of PCOS. In conclusion, androgen receptor coregulating lncRNA CTBP1-AS is associated with PCOS women and high expression of CTBP1-AS is a risk factor for PCOS in Kashmiri women

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Long non-coding RNAs: a valuable biomarker for metabolic syndrome

TL;DR: This review looked at lncRNAs and their molecular targets in the pathogenesis of signaling pathways, with a focus on diseases caused by long-term inflammation and the characteristics of the metabolic syndrome.
Journal ArticleDOI

Long non-coding RNA HLA-F antisense RNA 1 inhibits the maturation of microRNA-613 in polycystic ovary syndrome to promote ovarian granulosa cell proliferation and inhibit cell apoptosis

Xiaohua Li, +2 more
- 01 May 2022 - 
TL;DR: HLA-F-AS1 may inhibit the maturation of miR-613 in PCOS to promote ovarian granulosa cell proliferation and inhibit cell apoptosis.
References
More filters
Journal ArticleDOI

Consensus on women's health aspects of polycystic ovary syndrome (PCOS)

TL;DR: Current knowledge is summarized and knowledge gaps regarding various women's health aspects of PCOS are identified, including adolescence, hirsutism and acne, contraception, menstrual cycle abnormalities, quality of life, ethnicity, pregnancy complications, long-term metabolic and cardiovascular health and finally cancer risk.
Journal ArticleDOI

From Discovery to Function: The Expanding Roles of Long NonCoding RNAs in Physiology and Disease

TL;DR: The current strategies and approaches that have been employed to identify and characterize lncRNAs are outlined, which have been instrumental in revealing their multifaceted roles ranging from cis- to trans-regulation of gene expression and from epigenetic modulation in the nucleus to posttranscriptional control in the cytoplasm.
Journal ArticleDOI

Androgen-responsive long noncoding RNA CTBP1-AS promotes prostate cancer.

TL;DR: An androgen‐responsive long ncRNA, CTBP1‐AS, located in the AS region of C‐terminal binding protein 1 (CTBP1), which is a corepressor for androgen receptor is reported, providing new insights into the functions of ncRNAs that directly contribute to prostate cancer progression.
Journal ArticleDOI

Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences.

TL;DR: Data so far based on markers of subclinical atherosclerosis as well as retrospective and prospective cohort studies indicate a possible increased CVD risk, mainly for coronary heart disease.
Journal ArticleDOI

Hirsutism and acne in polycystic ovary syndrome.

TL;DR: Lower doses of these medications are as efficacious as high doses and have the advantage of decreased cost and an improved side-effect profile, recent studies have shown.
Related Papers (5)